Coastal Connecticut Research, LLC
New London, Connecticut, United States
Medical clinic in New London, Connecticut
342 Montauk Ave, New London, CT 06320
About Coastal Connecticut Research, LLC
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
GTx
3
Astellas Pharma Global Development, Inc.
2
Biohaven Pharmaceuticals, Inc.
2
Otsuka Pharmaceutical Development & Commercialization, Inc.
2
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
2
Shire
2
TauRx Therapeutics Ltd
2
TherapeuticsMD
2
Urovant Sciences GmbH
2
Warner Chilcott
2
Alcobra Ltd.
1
Clinical Trials at Coastal Connecticut Research, LLC
During the past decade, Coastal Connecticut Research, LLC conducted 19 clinical trials. In the 10-year time frame, 19 clinical trials started and 17 clinical trials were completed, i.e. on
average, 89.5% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 11 clinical trials were completed. i.e. 275%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Safety and Efficacy of A-007 Topical Gel in the Treatment of High-Grade Squamous Intraepithelial Lesions (HSIL) of the Cervix
2006-01-01
2008-06-01
Completed
147
Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or Naproxen
2006-10-04
2016-04-12
Completed
24,081
Evaluate the Safety and Efficacy of Bremelanotide in Women With Female Sexual Arousal Disorder (FSAD)
2006-02-01
2007-05-01
Completed
An Effectiveness and Safety Study of PF-04383119 for the Treatment of Pain in Interstitial Cystitis
2008-03-17
2009-04-15
Completed
65
Safety and Efficacy of Dapagliflozin as Monotherapy in Subjects With Type 2 Diabetes
2008-09-22
2009-12-29
Completed
497
Dose-optimization in Adolescents Aged 13-17 Diagnosed With Attention-deficit/Hyperactivity Disorder (ADHD) Using Extended-release Guanfacine HCl
2011-09-19
2013-05-16
Completed
314
Efficacy/Safety Study of Brisdelle™ (Formerly Known as Mesafem) in the Treatment of Vasomotor Symptoms (VMS)
2011-05-01
2012-02-01
Completed
614
Effect Of Pregabalin Treatment In Patients With Diabetic Nerve Pain Who Currently Use A Non-Steroid Anti-Inflammatory Drug (NSAID) For Another Pain
2011-12-01
2013-12-01
Completed
306
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Coastal Connecticut Research, LLC" #1 sponsor was "GTx" with 3 trials, followed by "Astellas Pharma Global Development, Inc." with 2 trials
sponsored, "Biohaven Pharmaceuticals, Inc." with 2 trials sponsored, "Otsuka Pharmaceutical Development & Commercialization, Inc." with 2 trials sponsored and "Pfizer's Upjohn has merged with Mylan to form Viatris Inc."
with 2 trials sponsored. Other sponsors include 20 different institutions and
companies that sponsored additional 25 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Coastal Connecticut Research, LLC"
#1 collaborator was "Alder Biopharmaceuticals, Inc." with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator, "Daré Bioscience, Inc." with 1 trials as a collaborator, "King Pharmaceuticals is now a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator and "The Cleveland Clinic" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were
collaborators in the rest 5 trials.
Clinical Trials Conditions at Coastal Connecticut Research, LLC
According to Clinical.Site data, the most researched conditions in "Coastal Connecticut Research, LLC" are
"Hot Flashes" (3 trials), "Menopause" (3 trials), "Stress Urinary Incontinence" (3 trials), "Vulvovaginal Atrophy" (3 trials) and "Agitation in Patients With Dementia of the Alzheimer's Type" (2 trials). Many other conditions were trialed in "Coastal Connecticut Research, LLC" in a lesser frequency.
Clinical Trials Intervention Types at Coastal Connecticut Research, LLC
Most popular intervention types in "Coastal Connecticut Research, LLC" are "Drug" (34 trials), "Other" (2 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (19 trials), "placebo" (4 trials), "AVP-786" (2 trials), "Estradiol" (2 trials) and "GTx-024" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Coastal Connecticut Research, LLC
The vast majority of trials in "Coastal Connecticut Research, LLC" are
21 trials for "All" genders and 15 trials for "Female" genders.
Clinical Trials Status at Coastal Connecticut Research, LLC
Currently, there are NaN active trials in "Coastal Connecticut Research, LLC".
undefined are not yet recruiting,
3 are recruiting,
2 are Active, not recruiting,
and 1 are Enrolling by invitation.
In total, there were 23 completed trials in Coastal Connecticut Research, LLC,
undefined suspended trials,
and 6 terminated clinical trials to date.
Out of the total trials that were conducted in Coastal Connecticut Research, LLC, 0 "Phase 1"
clinical trials were conducted, 10 "Phase 2" clinical
trials and 21 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 2 trials, and there were
also 1 trials that are defined as “Not Applicable".